{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T13:58:29Z","timestamp":1775483909397,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50 CA192937"],"award-info":[{"award-number":["P50 CA192937"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019736","name":"Farmer Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019736","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jmoldx.2023.02.005","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T22:00:18Z","timestamp":1679522418000},"page":"352-366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clonal Characterization and Somatic Hypermutation Assessment by Next-Generation Sequencing in Chronic Lymphocytic Leukemia\/Small Lymphocytic Lymphoma"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4048-8376","authenticated-orcid":false,"given":"Kseniya","family":"Petrova-Drus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Syed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2218-1490","authenticated-orcid":false,"given":"Wayne","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6544-9488","authenticated-orcid":false,"given":"Kasey","family":"Hutt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyssa M.","family":"Zlotnicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6502-6445","authenticated-orcid":false,"given":"Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Kamalska-Cyganik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidia","family":"Maciag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan G.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5448-4635","authenticated-orcid":false,"given":"Caleb","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Moung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinjuan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khedoudja","family":"Nafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeeyeon","family":"Baik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chad M.","family":"Vanderbilt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamal K.","family":"Benhamida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menglei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8090-5448","authenticated-orcid":false,"given":"Benjamin","family":"Durham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4245-752X","authenticated-orcid":false,"given":"Mark D.","family":"Ewalt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo","family":"Salazar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3659-6462","authenticated-orcid":false,"given":"Ivelise","family":"Rijo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tessara","family":"Baldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Mato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3806-059X","authenticated-orcid":false,"given":"Lindsey E.","family":"Roeker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikhail","family":"Roshal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria E.","family":"Arcila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2023.02.005_bib1","series-title":"WHO Classification of Tumours of the Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2017"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib2","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib3","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"Damle","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib4","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1182\/blood-2015-10-620864","article-title":"Should IGHV status and FISH testing be performed in all CLL patients at diagnosis? a systematic review and meta-analysis","volume":"127","author":"Parikh","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1182\/blood-2015-09-667675","article-title":"Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemia","volume":"127","author":"Thompson","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1182\/blood-2015-06-651125","article-title":"Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial","volume":"127","author":"Fischer","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib7","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1182\/blood-2014-10-606038","article-title":"Three-year follow-up of treatment-naive and previously treated patients with CLL and SLL receiving single-agent ibrutinib","volume":"125","author":"Byrd","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib8","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.18632\/oncotarget.6727","article-title":"Heightened BTK-dependent cell proliferation in unmutated chronic lymphocytic leukemia confers increased sensitivity to ibrutinib","volume":"7","author":"Guo","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib9","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1182\/blood-2017-10-810044","article-title":"Single-agent ibrutinib in treatment-na\u00efve and relapsed\/refractory chronic lymphocytic leukemia: a 5-year experience","volume":"131","author":"O'Brien","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib10","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM198312293092601","article-title":"Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms","volume":"309","author":"Arnold","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0065-2776(04)86002-4","article-title":"Mechanism and control of V(D)J recombination versus class switch recombination: similarities and differences","volume":"86","author":"Dudley","year":"2005","journal-title":"Adv Immunol"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib12","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3389\/fimmu.2013.00302","article-title":"The structural basis of antibody-antigen recognition","volume":"4","author":"Sela-Culang","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib13","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1182\/blood.V87.2.746.bloodjournal872746","article-title":"Ig VH gene mutational patterns indicate different tumor cell status in human myeloma and monoclonal gammopathy of undetermined significance","volume":"87","author":"Sahota","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.molimm.2015.01.001","article-title":"B cell variable genes have evolved their codon usage to focus the targeted patterns of somatic mutation on the complementarity determining regions","volume":"65","author":"Saini","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib15","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib16","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1172\/JCI3009","article-title":"Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors","volume":"102","author":"Fais","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib17","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/leu.2017.125","article-title":"Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: updated ERIC recommendations","volume":"31","author":"Rosenquist","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.leu.2404457","article-title":"ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia","volume":"21","author":"Ghia","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib19","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1038\/s41375-022-01604-2","article-title":"Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: the 2022 update of the recommendations by ERIC, the European Research Initiative on CLL","volume":"36","author":"Agathangelidis","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib20","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1182\/blood-2011-11-393694","article-title":"Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies","volume":"119","author":"Agathangelidis","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/blood-2006-03-012948","article-title":"Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations","volume":"109","author":"Stamatopoulos","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib22","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1016\/S2352-3026(14)00005-2","article-title":"Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study","volume":"1","author":"Baliakas","year":"2014","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib23","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/leu.2016.322","article-title":"Antigen receptor stereotypy in chronic lymphocytic leukemia","volume":"31","author":"Stamatopoulos","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib24","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood.2020007039","article-title":"Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL","volume":"137","author":"Agathangelidis","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib25","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jmoldx.2018.10.008","article-title":"Establishment of immunoglobulin heavy (IGH) chain clonality testing by next-generation sequencing for routine characterization of B-cell and plasma cell neoplasms","volume":"21","author":"Arcila","year":"2019","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib26","first-page":"804a","article-title":"MSK-LYMPHOCONE: data analysis pipeline and tools for immune repertoire analysis","volume":"17","author":"Syed","year":"2015","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib27","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1038\/leu.2012.246","article-title":"EuroClonality\/BIOMED-2 guidelines for interpretation and reporting of Ig\/TCR clonality testing in suspected lymphoproliferations","volume":"26","author":"Langerak","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib28","doi-asserted-by":"crossref","first-page":"W503","DOI":"10.1093\/nar\/gkn316","article-title":"IMGT\/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis","volume":"36","author":"Brochet","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib29","doi-asserted-by":"crossref","first-page":"W34","DOI":"10.1093\/nar\/gkt382","article-title":"IgBLAST: an immunoglobulin variable domain sequence analysis tool","volume":"41","author":"Ye","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib30","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1093\/bioinformatics\/btv456","article-title":"ARResT\/AssignSubsets: a novel application for robust subclassification of chronic lymphocytic leukemia based on B cell receptor IG stereotypy","volume":"31","author":"Bystry","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib31","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1093\/bioinformatics\/btu393","article-title":"Circlize implements and enhances circular visualization in R","volume":"30","author":"Gu","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib32","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1038\/s41375-019-0508-7","article-title":"Next-generation sequencing of immunoglobulin gene rearrangements for clonality assessment: a technical feasibility study by EuroClonality-NGS","volume":"33","author":"Scheijen","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jmoldx.2014.11.006","article-title":"High-throughput sequencing using the Ion Torrent personal genome machine for clinical evaluation of somatic hypermutation status in chronic lymphocytic leukemia","volume":"17","author":"McClure","year":"2015","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib34","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1038\/s41375-020-0923-9","article-title":"Immunoglobulin gene analysis in chronic lymphocytic leukemia in the era of next generation sequencing","volume":"34","author":"Davi","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib35","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/1471-2164-13-341","article-title":"A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers","volume":"13","author":"Quail","year":"2012","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib36","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/jcmm.12215","article-title":"Comprehensive characterization of immunoglobulin gene rearrangements in patients with chronic lymphocytic leukaemia","volume":"18","author":"Rene","year":"2014","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib37","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1002\/(SICI)1521-4141(199810)28:10<3384::AID-IMMU3384>3.0.CO;2-T","article-title":"Somatic hypermutation of human immunoglobulin heavy chain genes: targeting of RGYW motifs on both DNA strands","volume":"28","author":"D\u00f6rner","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1600-065X.1998.tb01434.x","article-title":"Monitoring and interpreting the intrinsic features of somatic hypermutation","volume":"162","author":"Neuberger","year":"1998","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.biochem.76.061705.090740","article-title":"Molecular mechanisms of antibody somatic hypermutation","volume":"76","author":"Di Noia","year":"2007","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib40","doi-asserted-by":"crossref","first-page":"e440","DOI":"10.1038\/bcj.2016.49","article-title":"Double IGHV DNA gene rearrangements in CLL: influence of mixed-mutated and -unmutated rearrangements on outcomes in CLL","volume":"6","author":"Heyman","year":"2016","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib41","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/leu.2011.49","article-title":"Immunoglobulin sequence analysis and prognostication in CLL: guidelines from the ERIC review board for reliable interpretation of problematic cases","volume":"25","author":"Langerak","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib42","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ajh.23396","article-title":"Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia","volume":"88","author":"Visco","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib43","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/bjh.12652","article-title":"Flow cytometric identification of 76 patients with biclonal disease among 5523 patients with chronic lymphocytic leukaemia (B-CLL) and its genetic characterization","volume":"164","author":"Kern","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib44","doi-asserted-by":"crossref","first-page":"e0137232","DOI":"10.1371\/journal.pone.0137232","article-title":"Single-cell analysis and next-generation immuno-sequencing show that multiple clones persist in patients with chronic lymphocytic leukemia","volume":"10","author":"Kriangkum","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2023.02.005_bib45","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/leu.2016.307","article-title":"Targeted deep sequencing reveals clinically relevant subclonal IgHV rearrangements in chronic lymphocytic leukemia","volume":"31","author":"Stamatopoulos","year":"2017","journal-title":"Leukemia"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157823000533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157823000533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:17:31Z","timestamp":1761502651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157823000533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1525157823000533"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2023.02.005","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clonal Characterization and Somatic Hypermutation Assessment by Next-Generation Sequencing in Chronic Lymphocytic Leukemia\/Small Lymphocytic Lymphoma","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2023.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}